Search Results - C. Recher
- Showing 1 - 8 results of 8
-
1
P556: CHANGES IN HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH NEWLY-DIAGNOSED ACUTE MYELOID LEUKEMIA RECEIVING IVOSIDENIB + AZACITIDINE OR PLACEBO + AZACITIDINE by A. Schuh, S. de Botton, C. Recher, S. Vives Polo, E. Zarzycka, J. Wang, G. Bertani, M. Heuser, R. Calado, S.-P. Yeh, J. Hui, S. Pandya, D. Gianolio, C. Chamberlain, H. Dohner, P. Montesinos
Published in HemaSphere (2022-06-01)Get full text
Article -
2
P510: THE IMPACT OF POST-REMISSION GRANULOCYTE COLONY-STIMULATING FACTOR USE IN THE PHASE 3 STUDIES OF VENETOCLAX COMBINATION TREATMENTS IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYEL... by C. DiNardo, K. Pratz, P. Panayiotidis, X. Wei, V. Vorobyev, Á. Illés, I. Kim, V. Ivanov, G. Ku, C. L. Miller, M. Zhang, F. Tatsch, J. Potluri, X. Schmidt, C. Recher
Published in HemaSphere (2022-06-01)Get full text
Article -
3
P421: LOWER VΓ9VΔ2 T CELLS RELATIVE FREQUENCIES PREDICT POORER SURVIVAL IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA by A.-C. Le Floch, F. Orlanducci, A. Le Roy, J.-F. Hamel, N. Ifrah, P. Cornillet-Lefebvre, J. Delaunay, C. Récher, E. Delabesse, A. Pigneux, M.-C. Béné, N. Vey, A.-S. Chretien, D. Olive
Published in HemaSphere (2022-06-01)Get full text
Article -
4
P430: MOLECULAR CHARACTERIZATION OF CLINICAL RESPONSE IN NEWLY-DIAGNOSED ACUTE MYELOID LEUKEMIA PATIENTS TREATED WITH IVOSIDENIB + AZACITIDINE COMPARED TO PLACEBO + AZACITIDINE by S. de Botton, S. Choe, D. Marchione, P. Montesinos, C. Recher, S. Vives Polo, E. Zarzycka, J. Wang, G. Bertani, M. Heuser, R. Calado, A. Schuh, S.-P. Yeh, J. Hui, S. Pandya, D. Gianolio, S. Daigle, C. DiNardo, H. Dohner
Published in HemaSphere (2022-06-01)Get full text
Article -
5
P557: HEMATOLOGIC IMPROVEMENTS WITH IVOSIDENIB + AZACITIDINE COMPARED WITH PLACEBO + AZACITIDINE IN PATIENTS WITH NEWLY-DIAGNOSED ACUTE MYELOID LEUKEMIA by H. Dohner, P. Montesinos, S. Vives Polo, E. Zarzycka, J. Wang, G. Bertani, M. Heuser, R. Calado, A. Schuh, S.-P. Yeh, A. de la Fuente, C. Cerchione, S. Daigle, J. Hui, S. Pandya, D. Gianolio, C. Recher, S. de Botton
Published in HemaSphere (2022-06-01)Get full text
Article -
6
P477: PHENOTYPICALLY-DEFINED STAGES OF LEUKEMIA ARREST PREDICT MAIN DRIVER MUTATIONS SUBGROUPS, AND OUTCOME IN ACUTE MYELOID LEUKEMIA by F. Vergez, L. Largeaud, S. Bertoli, M.-L. Nicolau-Travers, J.-B. Rieu, I. Vergnolle, E. Saland, A. Sarry, S. Tavitian, F. Huguet, M. Picard, J.-P. Vial, N. Lechevalier, A. Bidet, P.-Y. Dumas, A. Pigneux, I. Luquet, V. Mansat-De Mas, E. Delabesse, M. Carroll, G. Danet-Desnoyers, J.-E. Sarry, C. Recher
Published in HemaSphere (2022-06-01)Get full text
Article -
7
P555: A PHASE 1B/2 STUDY OF THE CD123-TARGETING ANTIBODY-DRUG CONJUGATE PIVEKIMAB SUNIRINE (IMGN632) IN COMBINATION WITH VENETOCLAX (VEN) AND AZACITIDINE (AZA) FOR PATIENTS WITH CD... by N. G. Daver, P. Montesinos, A. Aribi, G. Martinelli, J. Altman, G. Roboz, E. S. Wang, P. W. Burke, D. Jeyakumar, R. B. Walter, D. J. DeAngelo, H. P. Erba, A. Advani, L. Gastaud, X. Thomas, E. Todisco, N. Pemmaraju, L. Mendez, A. de la Fuente, G. Gaidano, A. Curti, N. Boissel, C. Recher, C. Schliemann, P. Vyas, C. M. Sloss, J. Wang, K. A. Malcolm, P. A. Zweidler-McKay, K. L. Sweet
Published in HemaSphere (2022-06-01)Get full text
Article -
8
C027 | RP2D DETERMINATION OF BLEXIMENIB IN COMBINATION WITH VEN+AZA: PHASE 1B STUDY IN ND & R/R ACUTE MYELOID LEUKEMIA WITH KMT2A/NPM1 ALTERATIONS by C. Papayannidis, A. H. Wei, J. E. Reyner, S. Garciaz, I. Aldoss, A.A. Piérola, A. Allred, J.M. Alonso Dominguez, L. Barreyro, P. Bories, N. Daskalakis, M.G. Della Porta, H. Döhner, A. D’souza, J. Dugan, A. Fathi, P. Fedele, L. Ferrante, R. Kobos, S. Gaj, A. Garrido Diaz, S. Garrido Paniagua, C. Guttke, E. Gyan, B. Hiebert, E. Jabbour, D. Trancucci, T. Bamidele, M. Jentzsch, H. Kantarjian, M. Konopleva, J. Krönke, M.L. Hütter-Krönke, C. Loefgren, O. Lomas, V. Mancini, I. Mantzaris, D. Morillo, J. Onions, K. Packman, C. Récher, C. Roellig, O. Salamero, P. Nagarajahastri, T. Sauer, E. Searle, N. Tovar, N. Vallet, L. Vaughan, G. Vega, P. Vyas, U. Platzbecker
Published in Haematologica (2025-09-01)Get full text
Article
